AmpC-BETA Lactamases among Enterobacteriaceae Isolated at a Tertiary Hospital, South Western Uganda
Martha Nakaye, Freddie Bwanga, Herbert Itabangi, Iramiot J. Stanley, Mwambi Bashir, Joel Bazira
Biotechnology Journal International · pp. 1026–1036 · Published 22 Aug 2014
10.9734/BBJ/2014/10570Abstract
AmpC-BETA Lactamases among Enterobacteriaceae Isolated at a Tertiary Hospital, South Western Uganda Aim: To characterize AmpC-beta lactamases among Enterobacteriaceae isolates from clinical samples at Mbarara Regional Referral Hospital. Study Design: Laboratory-based descriptive cross-sectional study Place and Duration of Study: Microbiology Department, Mbarara Regional Referral Hospital and MBN clinical Laboratories, between May to September 2013. Methodology: This study included 293 Enterobacteriaceae isolates recovered from clinical specimens that included blood, urine, stool and aspirates. AmpC Beta lactamase production was determined using disc placement method for cefoxitin at a break point of <18mm. Common AmpC plasmid mediated genes were EBC, ACC, FOX, DHA, CIT and MOX were; was determined by Multiplex PCR as described by Hanson and Perez-Perez. Results: Plasmid mediated AmpC phenotype was confirmed in 107 of the 293 (36.5%) cefoxitin resistant isolates with 30 isolates having more than one gene coding for resistance. The commonest source that harbored AmpC beta lactamases was urine and E. coli was the most common AmpC producer (59.5%). The genotypes detected in this study, included EBC (n=36), FOX (n=18), ACC (n=11), CIT (n=10), DHA (n=07) and MOX (n=1). Conclusion: Our findings showed that prevalence of AmpC beta- lactamase at MRRH was high (39.6), with EBC as the commonest genotype among Enterobacteriaceae Urine and E. coli were the commonest source and organism respectively that harbored AmpC beta-lactamases. There‘s rational antimicrobial therapy and antibiotic susceptibility tests should be requested by health workers especially patients presenting with urinary tract infections and bacteraemias.
Cited by 30
Huerta-Saquero A, Nefedova E, Shkil NN · PLoS One · 2025
Tekele SG, Mulatie Z, Gedefie A · Antimicrob Resist Infect Control · 2025
Garba Z, Kaboré B, Bonkoungou IJO · Antibiotics (Basel) · 2023
Rehana I, Pandey A, Singh P. · Cureus · 2023
Rodríguez-Guerrero E, Callejas-Rodelas JC, Navarro-Marí JM · Microorganisms · 2022
Awosile BB, Agbaje M, Adebowale O · Afr J Lab Med · 2022
Sadeghi M, Sedigh Ebrahim-Saraie H, Mojtahedi A. · New Microbes New Infect · 2022
Matloko K, Fri J, Ateba TP · PLoS One · 2021
Muriuki CW, Ogonda LA, Kyanya C · Microb Drug Resist · 2022
Najjuka CF, Kateete DP, Lodiongo DK · AAS Open Res · 2020
Related research
- Resistance Pattern of Nitrofurantoin of Uropathogens in Different Age Groups at Dr. Lal Path Labs, National Reference Laboratory, Rohini, Delhi — shares topic coverage
- Incidence of Enterobacteriaceae in Retail Meat Samples and Their Antibiotic Susceptibility — shares topic coverage
- Gram Negative Bacterial Diversity and Antimicrobial Resistance Profiles in Heavily Polluted Environmental Samples around The Sır Dam Lake (Turkey) — shares topic coverage
- Evaluation of the NDP Test, a Novel Chromogenic Test for Rapid Detection of Extended Spectrum β-Lactamase Producing Enterobacteriaceae — shares topic coverage
- Prevalence and Antibiotic Susceptibility of Enterobacteriaceae from Fish Samples in Allahabad, India — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
30
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.